
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
LRRK2 phosphorylates membrane-bound Rabs and is activated by GTP-bound Rab7L1 to promote recruitment to the trans-Golgi network
Zhiyong Liu, Nicole Bryant, Ravindran Kumaran, et al.
Human Molecular Genetics (2017) Vol. 27, Iss. 2, pp. 385-395
Open Access | Times Cited: 252
Zhiyong Liu, Nicole Bryant, Ravindran Kumaran, et al.
Human Molecular Genetics (2017) Vol. 27, Iss. 2, pp. 385-395
Open Access | Times Cited: 252
Showing 1-25 of 252 citing articles:
Parkinson disease and the immune system — associations, mechanisms and therapeutics
Eng‐King Tan, Yinxia Chao, Andrew B. West, et al.
Nature Reviews Neurology (2020) Vol. 16, Iss. 6, pp. 303-318
Closed Access | Times Cited: 361
Eng‐King Tan, Yinxia Chao, Andrew B. West, et al.
Nature Reviews Neurology (2020) Vol. 16, Iss. 6, pp. 303-318
Closed Access | Times Cited: 361
Rab family of small GTPases: an updated view on their regulation and functions
Yuta Homma, Shu Hiragi, Mitsunori Fukuda
FEBS Journal (2020) Vol. 288, Iss. 1, pp. 36-55
Open Access | Times Cited: 337
Yuta Homma, Shu Hiragi, Mitsunori Fukuda
FEBS Journal (2020) Vol. 288, Iss. 1, pp. 36-55
Open Access | Times Cited: 337
LRRK2 kinase in Parkinson's disease
Dario R. Alessi, Esther Sammler
Science (2018) Vol. 360, Iss. 6384, pp. 36-37
Open Access | Times Cited: 295
Dario R. Alessi, Esther Sammler
Science (2018) Vol. 360, Iss. 6384, pp. 36-37
Open Access | Times Cited: 295
LRRK2 and its substrate Rab GTPases are sequentially targeted onto stressed lysosomes and maintain their homeostasis
Tomoya Eguchi, Tomoki Kuwahara, Maria Sakurai, et al.
Proceedings of the National Academy of Sciences (2018) Vol. 115, Iss. 39
Open Access | Times Cited: 274
Tomoya Eguchi, Tomoki Kuwahara, Maria Sakurai, et al.
Proceedings of the National Academy of Sciences (2018) Vol. 115, Iss. 39
Open Access | Times Cited: 274
A pathway for Parkinson’s Disease LRRK2 kinase to block primary cilia and Sonic hedgehog signaling in the brain
Herschel S. Dhekne, Izumi Yanatori, Rachel C. Gomez, et al.
eLife (2018) Vol. 7
Open Access | Times Cited: 225
Herschel S. Dhekne, Izumi Yanatori, Rachel C. Gomez, et al.
eLife (2018) Vol. 7
Open Access | Times Cited: 225
Periphery and brain, innate and adaptive immunity in Parkinson’s disease
Ashley S. Harms, Sara A. Ferreira, Marina Romero‐Ramos
Acta Neuropathologica (2021) Vol. 141, Iss. 4, pp. 527-545
Open Access | Times Cited: 203
Ashley S. Harms, Sara A. Ferreira, Marina Romero‐Ramos
Acta Neuropathologica (2021) Vol. 141, Iss. 4, pp. 527-545
Open Access | Times Cited: 203
The Parkinson's disease VPS35[D620N] mutation enhances LRRK2-mediated Rab protein phosphorylation in mouse and human
Rafeeq Mir, Francesca Tonelli, Paweł Lis, et al.
Biochemical Journal (2018) Vol. 475, Iss. 11, pp. 1861-1883
Open Access | Times Cited: 193
Rafeeq Mir, Francesca Tonelli, Paweł Lis, et al.
Biochemical Journal (2018) Vol. 475, Iss. 11, pp. 1861-1883
Open Access | Times Cited: 193
LRRK2 links genetic and sporadic Parkinson's disease
Jillian H. Kluss, Adamantios Mamais, Mark Cookson
Biochemical Society Transactions (2019) Vol. 47, Iss. 2, pp. 651-661
Open Access | Times Cited: 187
Jillian H. Kluss, Adamantios Mamais, Mark Cookson
Biochemical Society Transactions (2019) Vol. 47, Iss. 2, pp. 651-661
Open Access | Times Cited: 187
Structural analysis of the full-length human LRRK2
Alexander Myasnikov, Hanwen Zhu, Patricia Hixson, et al.
Cell (2021) Vol. 184, Iss. 13, pp. 3519-3527.e10
Open Access | Times Cited: 157
Alexander Myasnikov, Hanwen Zhu, Patricia Hixson, et al.
Cell (2021) Vol. 184, Iss. 13, pp. 3519-3527.e10
Open Access | Times Cited: 157
Identification of Candidate Parkinson Disease Genes by Integrating Genome-Wide Association Study, Expression, and Epigenetic Data Sets
Demis A. Kia, David Zhang, Sebastian Guelfi, et al.
JAMA Neurology (2021) Vol. 78, Iss. 4, pp. 464-464
Open Access | Times Cited: 145
Demis A. Kia, David Zhang, Sebastian Guelfi, et al.
JAMA Neurology (2021) Vol. 78, Iss. 4, pp. 464-464
Open Access | Times Cited: 145
Increased LRRK2 kinase activity alters neuronal autophagy by disrupting the axonal transport of autophagosomes
C. Alexander Boecker, Juliet Goldsmith, Dan Dou, et al.
Current Biology (2021) Vol. 31, Iss. 10, pp. 2140-2154.e6
Open Access | Times Cited: 135
C. Alexander Boecker, Juliet Goldsmith, Dan Dou, et al.
Current Biology (2021) Vol. 31, Iss. 10, pp. 2140-2154.e6
Open Access | Times Cited: 135
Enhancer release and retargeting activates disease-susceptibility genes
Soohwan Oh, Jiaofang Shao, Joydeep Mitra, et al.
Nature (2021) Vol. 595, Iss. 7869, pp. 735-740
Open Access | Times Cited: 116
Soohwan Oh, Jiaofang Shao, Joydeep Mitra, et al.
Nature (2021) Vol. 595, Iss. 7869, pp. 735-740
Open Access | Times Cited: 116
LRRK2 and idiopathic Parkinson’s disease
Emily M. Rocha, Matthew T. Keeney, Roberto Di Maio, et al.
Trends in Neurosciences (2022) Vol. 45, Iss. 3, pp. 224-236
Open Access | Times Cited: 105
Emily M. Rocha, Matthew T. Keeney, Roberto Di Maio, et al.
Trends in Neurosciences (2022) Vol. 45, Iss. 3, pp. 224-236
Open Access | Times Cited: 105
Impact of 100 LRRK2 variants linked to Parkinson's disease on kinase activity and microtubule binding
Alexia F. Kalogeropulou, Elena Purlyte, Francesca Tonelli, et al.
Biochemical Journal (2022) Vol. 479, Iss. 17, pp. 1759-1783
Open Access | Times Cited: 87
Alexia F. Kalogeropulou, Elena Purlyte, Francesca Tonelli, et al.
Biochemical Journal (2022) Vol. 479, Iss. 17, pp. 1759-1783
Open Access | Times Cited: 87
Leucine-Rich Repeat Kinases
Dario R. Alessi, Suzanne R. Pfeffer
Annual Review of Biochemistry (2024) Vol. 93, Iss. 1, pp. 261-287
Closed Access | Times Cited: 17
Dario R. Alessi, Suzanne R. Pfeffer
Annual Review of Biochemistry (2024) Vol. 93, Iss. 1, pp. 261-287
Closed Access | Times Cited: 17
LRRK2 Biology from structure to dysfunction: research progresses, but the themes remain the same
Daniel C. Berwick, George R. Heaton, Sonia Azeggagh, et al.
Molecular Neurodegeneration (2019) Vol. 14, Iss. 1
Open Access | Times Cited: 144
Daniel C. Berwick, George R. Heaton, Sonia Azeggagh, et al.
Molecular Neurodegeneration (2019) Vol. 14, Iss. 1
Open Access | Times Cited: 144
LRRK2 regulation of immune-pathways and inflammatory disease
Rebecca L. Wallings, Malú G. Tansey
Biochemical Society Transactions (2019) Vol. 47, Iss. 6, pp. 1581-1595
Open Access | Times Cited: 125
Rebecca L. Wallings, Malú G. Tansey
Biochemical Society Transactions (2019) Vol. 47, Iss. 6, pp. 1581-1595
Open Access | Times Cited: 125
Glial phagocytic clearance in Parkinson’s disease
Marie‐Ève Tremblay, Mark Cookson, Laura Civiero
Molecular Neurodegeneration (2019) Vol. 14, Iss. 1
Open Access | Times Cited: 124
Marie‐Ève Tremblay, Mark Cookson, Laura Civiero
Molecular Neurodegeneration (2019) Vol. 14, Iss. 1
Open Access | Times Cited: 124
Lysosomal Dysfunction at the Centre of Parkinson’s Disease and Frontotemporal Dementia/Amyotrophic Lateral Sclerosis
Rebecca L. Wallings, Stewart W. Humble, Michael E. Ward, et al.
Trends in Neurosciences (2019) Vol. 42, Iss. 12, pp. 899-912
Open Access | Times Cited: 116
Rebecca L. Wallings, Stewart W. Humble, Michael E. Ward, et al.
Trends in Neurosciences (2019) Vol. 42, Iss. 12, pp. 899-912
Open Access | Times Cited: 116
Advances in elucidating the function of leucine-rich repeat protein kinase-2 in normal cells and Parkinson's disease
Matthew Taylor, Dario R. Alessi
Current Opinion in Cell Biology (2020) Vol. 63, pp. 102-113
Open Access | Times Cited: 116
Matthew Taylor, Dario R. Alessi
Current Opinion in Cell Biology (2020) Vol. 63, pp. 102-113
Open Access | Times Cited: 116
PPM1H phosphatase counteracts LRRK2 signaling by selectively dephosphorylating Rab proteins
Kerryn Berndsen, Paweł Lis, Wondwossen M Yeshaw, et al.
eLife (2019) Vol. 8
Open Access | Times Cited: 114
Kerryn Berndsen, Paweł Lis, Wondwossen M Yeshaw, et al.
eLife (2019) Vol. 8
Open Access | Times Cited: 114
Autophagy lysosomal pathway dysfunction in Parkinson's disease; evidence from human genetics
Konstantin Senkevich, Ziv Gan‐Or
Parkinsonism & Related Disorders (2019) Vol. 73, pp. 60-71
Open Access | Times Cited: 109
Konstantin Senkevich, Ziv Gan‐Or
Parkinsonism & Related Disorders (2019) Vol. 73, pp. 60-71
Open Access | Times Cited: 109
Membrane association but not identity is required for LRRK2 activation and phosphorylation of Rab GTPases
Rachel C. Gomez, Paulina S. Wawro, Paweł Lis, et al.
The Journal of Cell Biology (2019) Vol. 218, Iss. 12, pp. 4157-4170
Open Access | Times Cited: 101
Rachel C. Gomez, Paulina S. Wawro, Paweł Lis, et al.
The Journal of Cell Biology (2019) Vol. 218, Iss. 12, pp. 4157-4170
Open Access | Times Cited: 101
The Emerging Role of the Lysosome in Parkinson’s Disease
Alba Navarro-Romero, Marta Montpeyó, Marta Martínez‐Vicente
Cells (2020) Vol. 9, Iss. 11, pp. 2399-2399
Open Access | Times Cited: 101
Alba Navarro-Romero, Marta Montpeyó, Marta Martínez‐Vicente
Cells (2020) Vol. 9, Iss. 11, pp. 2399-2399
Open Access | Times Cited: 101
LRRK2‐mediated Rab10 phosphorylation in immune cells from Parkinson's disease patients
Farzaneh Atashrazm, Deborah Hammond, Gayathri Perera, et al.
Movement Disorders (2018) Vol. 34, Iss. 3, pp. 406-415
Closed Access | Times Cited: 94
Farzaneh Atashrazm, Deborah Hammond, Gayathri Perera, et al.
Movement Disorders (2018) Vol. 34, Iss. 3, pp. 406-415
Closed Access | Times Cited: 94